Respimat
Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Its developer, Boehringer Ingelheim, is currently conducting approved in the U.S. with a variety of their products, such as tiotropium and ipratropium/salbutamol. According to the manufacturer, the reusability of the inhaler reduces its carbon footprint by 71%.[1]
References
- ↑ "First reusable, propellant-free inhaler launched to cut plastic waste". Pharmaceutical Journal. 17 September 2019. Retrieved 19 November 2019.
Sources
| Oral |
| ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ophthalmic, otologic, nasal | 
| ||||||||||||||||||||||
| Urogenital | |||||||||||||||||||||||
| Rectal (enteral) | |||||||||||||||||||||||
| Dermal | 
| ||||||||||||||||||||||
| |||||||||||||||||||||||
-solution.jpg.webp)
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.